CRISPR Therapeutics AG
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
Switzerland
Country
Switzerland
Business Address
BAARERSTRASSE 14, ZUG, ,
Mailing Address
BAARERSTRASSE 14, ZUG, ,
Phone
6173154600
Fiscal Year End
1231
EIN
473173478
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 24, 2026 | View on SEC |
| 4 Insider stock transaction report | March 24, 2026 | View on SEC |
| 4 Insider stock transaction report | March 24, 2026 | View on SEC |
| 4 Insider stock transaction report | March 24, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 8-K Current report of material events | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
Annual Reports
10-K
February 12, 2026
- Successful launch of CASGEVY (exagamglogene autotemcel) for sickle cell disease and transfusion-dependent beta thalassemia, securing landmark regulatory approvals in the U.S., Europe, and UK.
- Reported total revenue of $350 million for fiscal year 2025, a substantial increase from $120 million in 2024, driven by collaboration revenue and initial CASGEVY sales.
Insider Trading
STRONG SELL
4 insiders
22 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Immunovant, Inc.
IMVT
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
Voyager Therapeutics, Inc.
VYGR
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.